Cyclacel Pharmaceuticals, Inc. Business Finance Contracts & Agreements
82 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (2)
- Loan Agreements (1)
- Note Agreements (1)
- Purchase Agreements (11)
- Registration Rights Agreements (5)
- Security Agreements (3)
- Stock Agreements (9)
- Subscription Agreements (3)
- Underwriting Agreements (9)
- Warrant Agreements (36)
- Warrant Exercise and Reload Agreement, dated November 13, 2024 (Filed With SEC on November 15, 2024)
- Form of Placement Agent Warrant (Filed With SEC on November 15, 2024)
- Form of Series D Warrant (Filed With SEC on November 15, 2024)
- Form of Series C Warrant (Filed With SEC on November 15, 2024)
- Form of Registration Rights Agreement, dated as of April 30, 2024, between the Company and the purchaser named therein (Filed With SEC on May 2, 2024)
- Securities Purchase Agreement, dated as of April 30, 2024, between the Company and the purchaser named therein (Filed With SEC on May 2, 2024)
- Form of Placement Agent Warrant (Filed With SEC on May 2, 2024)
- Form of Series B Warrant (Filed With SEC on May 2, 2024)
- Form of Series A Warrant (Filed With SEC on May 2, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on May 2, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on April 19, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 19, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 19, 2024)
- Form of Common Warrant (Filed With SEC on April 19, 2024)
- Securities Purchase Agreement, dated December 21, 2023, by and among the Company and Spiro Rombotis and Paul McBarron (Filed With SEC on December 26, 2023)
- Securities Purchase Agreement, dated December 21, 2023, by and among the Company and the Purchasers (Filed With SEC on December 26, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 26, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on December 26, 2023)
- Underwriting Agreement, dated March 12, 2021, by and between Cyclacel Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Filed With SEC on March 15, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on December 22, 2020)
- Form of Warrant (Filed With SEC on December 22, 2020)
- Form of Common Warrant (Filed With SEC on April 24, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on April 24, 2020)
- Securities Purchase Agreement, by and among Cyclacel Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto, dated as of April 21, 2020 (Filed With SEC on April 24, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on April 14, 2020)
- Form of Warrant (Filed With SEC on April 14, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on April 14, 2020)
- Form of Warrant to purchase shares of Cyclacel Pharmaceuticals, Inc.s Common Stock (previously filed as Exhibit 4.3 to the Registrants Registration Statement on Form S-1 (No.... (Filed With SEC on March 5, 2020)
- Common Stock Sales Agreement, dated October 4, 2018, by and between Cyclacel Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 4, 2018)
- 2,164,000 SHARES ofCommon Stock, 8,872 SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO 4,436,000 SHARES OF COMMON STOCK) AND 6,600,000Warrants (exercisable for... (Filed With SEC on July 21, 2017)
- COMMON STOCK PURCHASE WARRANT cyclacelpharmaceuticals, inc. (Filed With SEC on July 17, 2017)
- _________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on July 17, 2017)
- COMMON STOCK PURCHASE WARRANT cyclacelpharmaceuticals, inc. (Filed With SEC on June 30, 2017)
- [Form of Preferred Stock Certificate] (Filed With SEC on June 30, 2017)
- _________ SHARES ofCommon Stock, _______ SHARES OFSERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLEINTO ____ SHARES OF COMMON STOCK) AND __________Warrants (exercisable for ____... (Filed With SEC on June 30, 2017)
- Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 23, 2016)
- Cyclacel Pharmaceuticals,Inc. Up to $8,350,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 13, 2015)
- 2,857,143 Shares CYCLACEL PHARMACEUTICALS INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 4, 2014)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 14, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 14, 2013)
